| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| B CAPITAL GROUP MANAGEMENT, L.P. | 10%+ Owner | 1240 ROSECRANS AVE., 5TH FLOOR, MANHATTAN BEACH | B CAPITAL GROUP MANAGEMENT, L.P., By: /s/ Rajarshi Ganguly, Authorized Signatory | 24 Jul 2025 | 0001997306 |
| B Capital Global Growth III, L.P. | 10%+ Owner | 1240 ROSECRANS AVE., 5TH FLOOR, MANHATTAN BEACH | B Capital Global Growth III, L.P., By: /s/ Rajarshi Ganguly, Authorized Signatory | 24 Jul 2025 | 0001911138 |
| B Capital Healthcare I, L.P. | 10%+ Owner | 1240 ROSECRANS AVE., 5TH FLOOR, MANHATTAN BEACH | B Capital Healthcare I, L.P., By: /s/ Rajarshi Ganguly, Authorized Signatory | 24 Jul 2025 | 0001875322 |
| Hornet Co-Invest Investors, Ltd. | 10%+ Owner | 1240 ROSECRANS AVE., 5TH FLOOR, MANHATTAN BEACH | Hornet-Co-Invest Investors, Ltd., By: /s/ Rajarshi Ganguly, Authorized Signatory | 24 Jul 2025 | 0002077425 |
| Hornet Co-Invest, LP | 10%+ Owner | 1240 ROSECRANS AVE., 5TH FLOOR, MANHATTAN BEACH | Hornet-Co-Invest, L.P., By: /s/ Rajarshi Ganguly, Authorized Signatory | 24 Jul 2025 | 0002077424 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CARL | Common Stock | Conversion of derivative security | +3,680,506 | 3,680,506 | 24 Jul 2025 | By B Capital Global Growth III, L.P. | F1, F2, F5 | |||
| transaction | CARL | Common Stock | Purchase | $19,999,995 | +1,333,333 | +36% | $15.00 | 5,013,839 | 24 Jul 2025 | By B Capital Global Growth III, L.P. | F2, F5 |
| transaction | CARL | Common Stock | Conversion of derivative security | +2,376,472 | 2,376,472 | 24 Jul 2025 | By B Capital Healthcare I, L.P. | F1, F3, F5 | |||
| transaction | CARL | Common Stock | Conversion of derivative security | +931,452 | 931,452 | 24 Jul 2025 | By Hornet Co-Invest, L.P. | F1, F4, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CARL | Series B Preferred Stock | Conversion of derivative security | -1,445,020 | -100% | 0 | 24 Jul 2025 | Common Stock | 1,445,020 | By B Capital Global Growth III, L.P. | F1, F2, F5 | |||
| transaction | CARL | Series C Preferred Stock | Conversion of derivative security | -2,235,486 | -100% | 0 | 24 Jul 2025 | Common Stock | 2,235,486 | By B Capital Global Growth III, L.P. | F1, F2, F5 | |||
| transaction | CARL | Series B Preferred Stock | Conversion of derivative security | -1,445,020 | -100% | 0 | 24 Jul 2025 | Common Stock | 1,445,020 | By B Capital Healthcare I, L.P. | F1, F3, F5 | |||
| transaction | CARL | Series C Preferred Stock | Conversion of derivative security | -931,452 | -100% | 0 | 24 Jul 2025 | Common Stock | 931,452 | By B Capital Healthcare I, L.P. | F1, F3, F5 | |||
| transaction | CARL | Series C Preferred Stock | Conversion of derivative security | -931,452 | -100% | 0 | 24 Jul 2025 | Common Stock | 931,452 | By Hornet Co-Invest, L.P. | F1, F4, F5 |
| Id | Content |
|---|---|
| F1 | Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date. |
| F2 | Shares held by B Capital Global Growth III, L.P. |
| F3 | Shares held by B Capital Healthcare I, L.P. |
| F4 | Shares held by Hornet Co-Invest, L.P. |
| F5 | B Capital Group Management, LP is the manager of B Capital Global Growth III, L.P. and B Capital Healthcare I, L.P. Hornet-Co-Invest Investors, Ltd. is the ultimate general partner of Hornet Co-Invest, L.P. (Hornet Co-Invest, L.P., together with B Capital Healthcare I, L.P., and B Capital Global Growth III, L.P., "B Capital"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. |